| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $1.62B | $1.25B | $937.4M |
| YoY Revenue Growth % | +29.6% | +33.3% | — |
| Gross Profit | $1.24B | $950.9M | — |
| Gross Margin % | 76.7% | 76.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$52.6M | -$190.0M | -$323.3M |
| Operating Margin % | -3.2% | -15.2% | -34.5% |
| Net Income (GAAP) | -$9.1M | -$154.9M | -$286.7M |
| EBITDA (Normalized) | -$29.6M | -$173.8M | -$289.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $236.2M | $131.7M | -$11.8M |
| Capital Expenditures (CapEx) | $28.8M | $20.2M | $42.2M |
| Free Cash Flow (FCF) | $207.4M | $111.5M | -$54.0M |
| FCF Margin % | 12.8% | 8.9% | -5.8% |
| Return on Invested Capital (ROIC %) | -2.6% | -11.8% | -3.2% |
| Cash & Short-Term Equivalents | $318.8M | $227.6M | — |
| Total Debt (Short + Long Term) | $504.1M | $429.8M | $3.14B |
| Total Stockholders' Equity | $1.42B | $1.07B | $6.44B |